US 8563614
Use of treprostinil to treat neuropathic diabetic foot ulcers
granted A61KA61K31/557A61P
Quick answer
US patent 8563614 (Use of treprostinil to treat neuropathic diabetic foot ulcers) held by United Therapeutics Corporation expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/557, A61P, A61P17/02, A61P29/00